| Dates | Location | Tuition |
|---|---|---|
| Jun 7, 2010 - Jun 11, 2010 | Philadelphia | $8,450 |
The biotechnology and pharmaceuticals industries have experienced rapid advances in science, increasingly complex alliances between research and development, intense global competition, mega-mergers, and new regulations and shifts in policies. To successfully lead your company through this complex environment, you need to understand the profound strategic implications of these changes — and understand them across the key functions of the business: discovery, marketing, finance, and business development.
The Wharton/Windhover Program gives current and future industry leaders insight into the changes and challenges of each key area of the business. Taught by CEOs, top researchers and drug developers, senior marketing executives, policy and pricing experts, industry deal-makers, and Wharton faculty, the course will give you broad perspectives and practical tools. Faculty discuss the management implications of the new techniques of drug discovery, marketing and pricing in the current environment, financial evaluation and deals, and mergers and alliances.
The Wharton/Windhover Program combines the academic insights of health care management faculty and industry analysts with the best practical experience of senior drug company executives. This academia-industry collaboration distills the best of academic research and practical experience into a powerful and focused one-week session.
Tuition for Philadelphia programs includes lodging and meals. Prices are subject to change. Program Consultants are available to provide more information on course specifics and discuss how this program might meet your needs. Please contact them by telephone at +1 215.898.1776 or by e-mail.
This program offers an integrated approach. Unlike other courses in which executives serve only as guest speakers, industry leaders are part of the faculty. In addition to gaining the perspective of the industry experts — as well as those of the other participants — you will study industry-specific cases and discuss your own current challenges.
Wharton/Windhover Program Session Topics
- Drug Discovery: New Tools and Management Implications
- Managing Drug Development
- Marketing and Pricing To Maximize Value
- Financial Tools for Valuing Deals and Firms
- Alliances and Acquisitions: Trends and Strategies
Related Pharmaceutical and Biotech Articles
Knowledge@Wharton
Requires a one-time complimentary registration to Knowledge@Wharton.
- "Can Aventis Fight Off Its Hostile Suitor?" (February 2004)
- "Insurance Industry Conference Looks at Terrorism, Drug Coverage, Malpractice Insurance, and M&As" (January 2004)
- "Analyzing Brand-Name and Generic Drug Costs in the U.S. and Eight Other Countries" (November 2003)
Wharton@Work: E-Buzz
The Wharton/Windhover Program is designed for senior managers in the pharmaceuticals and biotechnology industries, particularly functional specialists with at least five years of industry experience, who are moving into positions with new responsibilities that demand a broader vision of the industry and their business.
We encourage companies to send cross-functional teams of executives to leverage the application and value of the program. Additional group benefits are available when four or more participants attend a program.
Gain broad perspectives on changes in pharmaceuticals and biotechnology from leading faculty and executives. Become better prepared to compete strategically and globally. You will:
- Develop an understanding of key business tools and approaches in R&D, marketing, strategy, finance, M&A, and alliances.
- Acquire a cross-functional view of challenges to avoid disciplinary blind spots.
- Interact with an outstanding group of industry peers to share ideas and build a network for the future.
PATRICIA
DANZON, PhD
Professor of Health Care Management and Insurance and Risk Management
The Wharton School
ROGER
LONGMAN
Editor, In Vivo
Windhover Information